专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

11. 发明申请

WO2002089699A3 MEDICAL DEVICE AND METHODS OF USE FOR GLAUCOMA TREATMENT 审中-公开
公开(公告)号：WO2002089699A3
公开(公告)日：2002-11-14
申请号：PCT/US2002/014230
申请日：2002-05-03
申请人： GLAUKOS CORPORATION
发明人： TU, Hosheng , SMEDLEY, Gregory, T. , NIKSCH, Barbara , HAFFNER, David, S.
IPC分类号： A61M29/00
摘要： The invention relates generally medical devices and methods for the treatment of glaucoma in an animal eye (10) and, more particularly, to medical devices and methods for treating tissue of the trabecular meshwork (21) and /or Schlemm's canal (22) of the eye (10) to restore or rejuvenate a portion or all of the normal physiological function of directing aqueous outflow for maintaining a normal intraocular pressure in the eye (10).

12. 发明申请

WO2022241266A1 MATERIALS AND METHODS FOR PUNCTAL PLUGS 审中-公开
公开(公告)号：WO2022241266A1
公开(公告)日：2022-11-17
申请号：PCT/US2022/029272
申请日：2022-05-13
申请人： GLAUKOS CORPORATION
发明人： CURRY, Kenneth , TRAN, William
IPC分类号： A61F2/14 , A61F9/007 , A61F9/00 , A61F9/0017 , C08L1/286 , C08L5/08
摘要： A punctum plug or lacrimal insert is constructed of a monolithic material, such that the punctum plug is configured to turn approximately 90 degrees upon insertion into a canaliculus of an eye. The punctum plug or lacrimal insert may include high-molecular-weight polysaccharide and added plasticizers.

13. 发明申请

WO2017087713A1 DELIVERY DEVICE SYSTEMS AND IMPLANTS FOR TREATING GLAUCOMA 审中-公开
标题翻译：输送装置系统和用于治疗青光眼的植入物
公开(公告)号：WO2017087713A1
公开(公告)日：2017-05-26
申请号：PCT/US2016/062598
申请日：2016-11-17
申请人： GLAUKOS CORPORATION
发明人： FJIELD, Todd, N. , KALINA, Charles, Raymond , CRIMALDI, Douglas, Daniel
IPC分类号： A61F9/007
CPC分类号： A61F9/00781
摘要： An ocular implant (100) has a distal cutting tip for piercing through a trabecular meshwork to allow a distal portion of the stent to be positioned within Schlemm's canal. A snorkel portion of the implant remains in the anterior chamber and conducts aqueous humor from the anterior chamber into Schlemm's canal. A delivery device has tines (424) that splay to release the implant when the tines are unsheathed from an outer sheath (426) of the delivery device.
摘要翻译：眼用植入物（100）具有用于刺穿小梁网的远侧切割尖端，以允许支架的远侧部分定位在施累姆氏管内。植入物的呼吸管部分保留在前房中，并将房水从前房导入施累姆氏管。输送装置具有尖齿（424），当尖齿从输送装置的外部护套（426）上拔出时，尖端（424）展开以释放植入物。

14. 发明申请

WO2017015633A1 OCULAR IMPLANTS FOR REDUCTION OF INTRAOCULAR PRESSURE 审中-公开
标题翻译：用于减少内压的OCURAR植入物
公开(公告)号：WO2017015633A1
公开(公告)日：2017-01-26
申请号：PCT/US2016/043752
申请日：2016-07-22
申请人： GLAUKOS CORPORATION
发明人： FJIELD, Todd , CRIMALDI, Douglas, Daniel , KALINA, Charles, Raymond, Jr. , HEITZMANN, Harold, A.
IPC分类号： A61F9/007
CPC分类号： A61F9/00781 , A61F2/82 , A61F2210/0061
摘要： Devices and methods for treating intraocular pressure are disclosed. The devices include shunts (130) for draining aqueous humor from the anterior chamber to the uveoscleral outflow pathway, including the supraciliary space and the suprachoroidal space.A swellable material (990) can be positioned through lumen (136) at the outflow portion (134) in order to increase the outflow space.
摘要翻译：公开了用于治疗眼内压的装置和方法。所述装置包括用于将房水从前房排出至包括上腔空间和脉管外空间的视神经管流出通道的分流器（130）。可膨胀材料（990）可以通过流出部分（134）处的内腔（136）定位）以增加流出空间。

15. 发明申请

WO2016154066A2 GONIOSCOPIC DEVICES 审中-公开
标题翻译： GONIOSCOPIC设备
公开(公告)号：WO2016154066A2
公开(公告)日：2016-09-29
申请号：PCT/US2016/023296
申请日：2016-03-18
申请人： GLAUKOS CORPORATION
发明人： KALINA, Charles, Raymond , BURNS, Thomas, W. , CALCATERRA, Chris , COLLINS, Edward , MCCAULEY, Timothy , HAFFNER, David, S. , HENDERSON, Steven, M.
IPC分类号： A61B3/117
CPC分类号： A61B3/117 , A61B3/0033 , A61B3/0083
摘要： A gonioscopic attachment can attach to a gonioscope and can include atraumatic retention elements that are configured to engage an eye to retain the gonioscope relative to the eye. Tire gonioscopic attachment can be configured to position the gonioscope so that at least a portion of the concave distal surface of the gonioscopic optical element is spaced apart from the eye, and/or so that the curvature of the distal surface is angularly offset from the curvature of the eye. The gonioscope can include a fixation point configured to be visible to the subject when the gonioscope is positioned on the eye. In some embodiments, the retention elements can be incorporated directly into the gonioscope. A coupling mechanism can couple the gonioscope to a lid speculum. The gonioscope can include a light pipe, which can be configured to directly light into the eye.
摘要翻译：前庭附件可以附接到眼镜上，并且可以包括构造成接合眼睛以保持眼镜相对于眼睛的无创伤保留元件。轮胎前视镜附件可以被配置成定位测角仪，使得前视角光学元件的凹形远侧表面的至少一部分与眼睛间隔开，和/或使得远侧表面的曲率与曲率成角度地偏移的眼睛。测角仪可以包括被配置成当眼镜放置在眼睛上时被检者可见的固定点。在一些实施例中，保留元件可以直接结合在眼镜中。耦合机构可以将测角仪连接到盖子窥镜。眼镜可以包括一个可以配置成直接照进眼睛的光管。

16. 发明申请

WO2010093945A2 UVEOSCLERAL DRUG DELIVERY IMPLANT AND METHODS FOR IMPLANTING THE SAME 审中-公开
公开(公告)号：WO2010093945A2
公开(公告)日：2010-08-19
申请号：PCT/US2010/024128
申请日：2010-02-12
申请人： GLAUKOS CORPORATION , HAFFNER, David , CURRY, Kenneth
发明人： HAFFNER, David , CURRY, Kenneth
IPC分类号： A61F9/00 , A61M37/00
CPC分类号： A61F9/00781 , A61F9/0017 , A61K31/00 , A61L27/18 , A61L27/54 , A61L2300/604 , A61L2430/16 , A61M25/00 , A61M25/0105 , A61M27/00 , A61M37/00 , A61M2025/0286 , A61M2210/0612 , C08L67/04
摘要： Devices and methods for treating intraocular pressure are disclosed. The devices include drug delivery implants for treating ocular tissue. Optionally, the devices also include shunts for draining aqueous humor from the anterior chamber to the uveoscleral outflow pathway, including the supraciliary space and the suprachoroidal space. The drug delivery implants can be implanted in ab interno or ab externo procedures.
摘要翻译：公开了用于治疗眼内压的装置和方法。该装置包括用于治疗眼组织的药物递送植入物。可选地，所述装置还包括用于将房水从前房排出至囊肿流出路径的分流器，包括上附近的空间和脉管外空间。药物输送植入物可以以内部或外部程序植入。

17. 发明申请

WO2005016418A1 DEVICES AND METHODS FOR GLAUCOMA TREATMENT 审中-公开
标题翻译： GLAUCOMA治疗的装置和方法
公开(公告)号：WO2005016418A1
公开(公告)日：2005-02-24
申请号：PCT/US2004/024988
申请日：2004-08-03
申请人： GLAUKOS CORPORATION , HAFFNER, David , SMEDLEY, Gregory, T. , TU, Hosheng
发明人： HAFFNER, David , SMEDLEY, Gregory, T. , TU, Hosheng
IPC分类号： A61M5/00
CPC分类号： A61F9/00781
摘要： Intraocular stents (229) and applicators are disclosed for treating glaucoma. The stents (229) are configured to extend between the anterior chamber of the eye and Schlemm's canal (22) for enhancing outflow of aqueous from the anterior chamber (20) so as to reduce intraocular pressure. The stents (229) can have features for anchoring the stent into Schlemm's canal (22) as well as preventing the walls of Schlemm's canal (22) from closing the outlet of the stents (229). The applicators can be steerable so as to make implantation easier. Additionally, the applicators can be configured to hold a plurality of stents so that multiple stents can be implanted through one incision without removing the applicator from the incision between serial implantations.
摘要翻译：公开了用于治疗青光眼的眼内支架（229）和敷贴器。支架（229）构造成在眼睛的前房和施乐姆管（22）之间延伸，以增强从前房（20）流出的水分，以便降低眼内压。支架（229）可以具有用于将支架锚定到施莱姆管（22）中的特征，以及阻止施莱姆管（22）的壁关闭支架的出口（229）。施加器可以是可操纵的，以便使植入更容易。此外，施用器可以被配置成保持多个支架，使得可以通过一个切口植入多个支架，而不会从串联注入之间的切口移除施加器。

18. 发明申请

WO2002102274A2 GLAUCOMA DEVICE AND METHODS THEREOF 审中-公开
标题翻译： GLAUCOMA设备及其方法
公开(公告)号：WO2002102274A2
公开(公告)日：2002-12-27
申请号：PCT/US2002/013872
申请日：2002-05-01
申请人： GLAUKOS CORPORATION
发明人： BERGHEIM, Olav , TU, Hosheng , GHARIB, Morteza
IPC分类号： A61F
CPC分类号： A61F9/00781
摘要： A glaucoma treatment device (31, 61) for directing the flow of aqueous humor and reducing intraocular pressure for angle closure glaucoma is disclosed. The glaucoma device (31, 61) comprises an aqueous transporting element (31, 61) for transporting aqueous humor to bypass dysfunctional anatomical iris closure and restoring existing outflow pathways of the anatomical iris closure. The aqueous transporting element (31, 61) has an inlet end (34, 90) and an outlet end (35, 92), wherein the inlet end (34, 90) is positioned inside an anterior chamber (20) of an eye (10) beyond an edge (120) of the dysfunctional anatomic iris closure and the outlet end (35, 92) is positioned in proximity of trabecular meshwork (21) of the eye (10). The device (31, 61) also serves to stent the space between the iris (13) and an inner surface (126) of a cornea (12) of the eye (10).
摘要翻译：公开了一种用于引导房水流动并降低眼内压的闭角型青光眼的青光眼治疗装置（31,61）。青光眼装置（31,61）包括用于输送房水以绕过功能障碍的解剖虹膜闭合并恢复解剖虹膜闭合的现有流出通道的水性输送元件（31,61）。水输送元件（31,61）具有入口端（34,90）和出口端（35,92），其中入口端（34,90）位于眼睛的前房（20）内部 10）超出功能障碍性解剖虹膜闭合的边缘（120）并且出口端（35,92）定位在眼睛（10）的小梁网（21）附近。装置（31,61）还用于支撑虹膜（13）和眼睛（10）的角膜（12）的内表面（126）之间的空间。

19. 发明申请

WO2002089699A2 MEDICAL DEVICE AND METHODS OF USE FOR GLAUCOMA TREATMENT 审中-公开
标题翻译：医疗器械及其用于治疗玻璃体的方法
公开(公告)号：WO2002089699A2
公开(公告)日：2002-11-14
申请号：PCT/US2002/014230
申请日：2002-05-03
申请人： GLAUKOS CORPORATION
发明人： TU, Hosheng , SMEDLEY, Gregory, T. , NIKSCH, Barbara , HAFFNER, David, S.
IPC分类号： A61D
CPC分类号： A61F2/16 , A61F9/00781 , A61K9/0048
摘要： The invention relates generally medical devices and methods for the treatment of glaucoma in an animal eye (10) and, more particularly, to medical devices and methods for treating tissue of the trabecular meshwork (21) and /or Schlemm's canal (22) of the eye (10) to restore or rejuvenate a portion or all of the normal physiological function of directing aqueous outflow for maintaining a normal intraocular pressure in the eye (10).
摘要翻译：本发明一般涉及用于治疗动物眼（10）中的青光眼的医疗装置和方法，更具体地涉及用于治疗小梁网（21）和/或施莱姆氏管（22）的组织的医疗装置和方法眼（10）恢复或恢复引导水流出物的一部分或全部正常生理功能以维持眼睛（10）中的正常眼内压。

20. 发明申请

WO2021247690A1 RHO KINASE INHIBITOR RELEASING IMPLANTS AND RELATED METHODS OF USE 审中-公开
公开(公告)号：WO2021247690A1
公开(公告)日：2021-12-09
申请号：PCT/US2021/035431
申请日：2021-06-02
申请人： GLAUKOS CORPORATION
发明人： BURNS, Tom , YANG, Jia-Ying , HUGHES, Patrick Michael
IPC分类号： A61K9/00 , A61K31/472 , A61K31/4409 , A61K31/551 , A61K47/34 , A61K47/32 , A61P27/02 , A61F2210/0004 , A61F2210/0076 , A61F2220/0016 , A61F2250/0067 , A61F9/0017 , A61K31/00 , A61K9/0051 , A61L2300/204 , A61L2300/432 , A61L2300/604 , A61L2300/62 , A61L27/18 , A61L27/34 , A61L27/54 , A61L27/58 , C08L2201/06 , C08L2203/02 , C08L23/0853 , C08L67/04 , C08L83/08
摘要： The present disclosure is directed to intracameral implants for treating and/or preventing corneal disorders, diseases, and/or conditions, such as corneal endothelial dystrophies. The intracameral implants can be configured to provide a sustained release of a therapeutic agent, such as a Rho kinase inhibitor, for a prolonged period of time. The intracameral implants can include a non-bioresorbable anchor or a bioresorbable matrix.

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式